Musculoskeletal News and Research

RSS

Researchers regrow hair strands on damaged skin

By stirring crosstalk among skin cells that form the roots of hair, researchers report they have regrown hair strands on damaged skin. The findings better explain why hair does not normally grow on wounded skin, and may help in the search for better drugs to restore hair growth, say the study's authors.

28 Nov 2018

Study highlights a new predictor of type 2 diabetes

Henry Ford Hospital researchers may have unknowingly happened on a new predictor of type 2 diabetes as part of a new ultrasound shoulder study.

20 Nov 2018

Shoulder ultrasounds could be used to predict diabetes

Researchers have shown that it may be possible to use ultrasound scans of a muscle in the shoulder to predict diabetes.

19 Nov 2018

New methods for preserving shoulder function, quality of life in breast cancer patients

After a prophylactic double mastectomy in 2015, Tina Harrison discovered that she did, indeed, have breast cancer--it just hadn't been detected.

19 Nov 2018

Harvard researchers use echidna forelimb model to shed light on mammal evolution

These days, mammals can use their forelimbs to swim, jump, fly, climb, dig and just about everything in between, but the question of how all that diversity evolved has remained a vexing one for scientists.

18 Nov 2018

New guidelines for detecting and managing sarcopenia to be launched in the UK

Newcastle University experts are chairing a national session on new guidelines for the early detection and treatment of sarcopenia - a loss of muscle strength that affects many older people in the UK.

15 Nov 2018

Survey: Complementary and alternative medicine is widely used by general population in England

Use of practitioner-led complementary and alternative medicine (CAM), such as acupuncture, massage, osteopathy and chiropractic treatment, rose from 12 per cent of the population in 2005 to 16 per cent of the population in 2015, according to a survey led by researchers at the University of Bristol's Centre for Academic Primary Care.

14 Nov 2018

Newer technology with modular dual mobility components lowers risk of dislocation

Hip replacement surgery is highly successful in relieving pain, restoring mobility and improving quality of life. More than 330,000 procedures are performed each year in the United States, and that number is expected to almost double by the year 2030.

8 Nov 2018

Pilates exercise program offers many benefits for people with musculoskeletal conditions

A Musculoskeletal Care study is the first to investigate individual perceptions of the impact of a Pilates exercise program on the daily lives of people with chronic conditions.

7 Nov 2018

Study examines timing of musculoskeletal adverse events that develop during statin therapy

Statins have been linked with muscle pain and other musculoskeletal adverse events in some patients. A new Pharmacology Research & Perspectives study has examined the timing of MAEs that develop during statin therapy and determined whether concomitant drugs used concurrently with statin therapy shifts the timing of MAEs.

7 Nov 2018

UCLA researchers investigate how a protein factor contributes to cancer cell migration

UCLA researchers have discovered a new protein factor that contributes to a fibroblast cell's ability to migrate to a wound and participate in its healing process. The study's results could help scientists prevent cancer cells from using the same mechanisms to move throughout the body and spread.

1 Nov 2018

Toxic protein assemblies found to play beneficial role in muscle generation

Toxic protein assemblies, or "amyloids," long considered to be key drivers in many neuromuscular diseases, also play a beneficial role in the development of healthy muscle tissue, University of Colorado Boulder researchers have found.

1 Nov 2018

A fully human cell culture system for growing skin keratinocytes

Breakthrough research to culture human skin cells called keratinocytes to produce skin grafts has been published by a team of researchers from Duke-NUS Medical School and the Singapore General Hospital.

31 Oct 2018

Almost 60% of truck drivers experience musculoskeletal pain, finds Canadian study

Almost 60 per cent of truck drivers in a recent Canadian study reported experiencing musculoskeletal pain and discomfort on the job, even though it may be preventable.

30 Oct 2018

Volunteering for peer counseling programs benefits people with lupus

Conventional wisdom has it that volunteering is good for you, and a study at Hospital for Special Surgery shows that to be true for people with lupus volunteering in a peer support and education program.

23 Oct 2018

Researchers identify common genetic connection in lung conditions

An international research team led by members of the University of Colorado School of Medicine faculty has identified a genetic connection between rheumatoid arthritis-associated interstitial lung disease and idiopathic pulmonary fibrosis.

22 Oct 2018

Combination of Opdivo and Yervoy shows four-year survival benefits in patients with advanced melanoma

Bristol-Myers Squibb Company today announced four-year data from the Phase 3 CheckMate -067 clinical trial - the longest follow-up to date - which continues to demonstrate durable, long-term survival benefits with the first-line combination of Opdivo (nivolumab) and Yervoy (ipilimumab), versus Yervoy alone, in patients with advanced melanoma.

22 Oct 2018

Merck presents MK-1454 Phase 1 data for treatment of advanced solid tumors or lymphomas

Merck, known as MSD outside the United States and Canada, today announced the first presentation of preliminary data from a Phase 1 clinical trial evaluating MK-1454, an investigational STING (stimulator of interferon genes) agonist, as monotherapy and in combination with KEYTRUDA (pembrolizumab), Merck's anti-PD-1 therapy, in patients with advanced solid tumors or lymphomas.

22 Oct 2018

LYNPARZA Phase III SOLO-1 results show improved outcome for patients with advanced BRCA-mutated ovarian cancer

AstraZeneca and Merck & Co., Inc., Kenilworth, N.J., today announced detailed results from the Phase III SOLO-1 trial testing LYNPARZA (olaparib) 300 mg tablets twice-daily as a maintenance treatment for patients with newly diagnosed advanced BRCA-mutated ovarian cancer who were in complete or partial response following 1st-line standard platinum-based chemotherapy.

22 Oct 2018

Merck presents KEYNOTE-057 trial results for patients with high-risk non-muscle invasive bladder cancer

Merck, known as MSD outside the United States and Canada, today announced the first presentation of results from an interim analysis of KEYNOTE-057, a Phase 2 trial evaluating KEYTRUDA, Merck's anti-PD-1 therapy, for previously treated patients with high-risk non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ or CIS plus papillary disease (Cohort A).

22 Oct 2018

Musculoskeletal News and Research

Researchers regrow hair strands on damaged skin

Study highlights a new predictor of type 2 diabetes

Shoulder ultrasounds could be used to predict diabetes

New methods for preserving shoulder function, quality of life in breast cancer patients

Harvard researchers use echidna forelimb model to shed light on mammal evolution

New guidelines for detecting and managing sarcopenia to be launched in the UK

Survey: Complementary and alternative medicine is widely used by general population in England

Newer technology with modular dual mobility components lowers risk of dislocation

Pilates exercise program offers many benefits for people with musculoskeletal conditions

Study examines timing of musculoskeletal adverse events that develop during statin therapy

UCLA researchers investigate how a protein factor contributes to cancer cell migration

Toxic protein assemblies found to play beneficial role in muscle generation

A fully human cell culture system for growing skin keratinocytes

Almost 60% of truck drivers experience musculoskeletal pain, finds Canadian study

Volunteering for peer counseling programs benefits people with lupus

Researchers identify common genetic connection in lung conditions

Combination of Opdivo and Yervoy shows four-year survival benefits in patients with advanced melanoma

Merck presents MK-1454 Phase 1 data for treatment of advanced solid tumors or lymphomas

LYNPARZA Phase III SOLO-1 results show improved outcome for patients with advanced BRCA-mutated ovarian cancer

Merck presents KEYNOTE-057 trial results for patients with high-risk non-muscle invasive bladder cancer

Managing vibration in IVF laboratories

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Latest News